학술논문

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy.
Document Type
Article
Source
Military Medical Research; 4/28/2023, Vol. 10 Issue 1, p1-16, 16p
Subject
IMMUNE checkpoint inhibitors
NANOMEDICINE
DRUG side effects
CANCER treatment
IMMUNE checkpoint proteins
IPILIMUMAB
Language
ISSN
20957467
Abstract
Copyright of Military Medical Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)